Vuong Trieu - 14 Jun 2023 Form 4 Insider Report for Oncotelic Therapeutics, Inc. (OTLC)

Role
CHAIRMAN AND CEO, Director, 10%+ Owner
Signature
/s/ Trieu, Vuong
Issuer symbol
OTLC
Transactions as of
14 Jun 2023
Net transactions value
+$13,040
Form type
4
Filing time
16 Jun 2023, 12:00:08 UTC
Previous filing
31 May 2023
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLC Common Stock Purchase $13,040 +400,000 +0.44% $0.0326 91,444,217 14 Jun 2023 Direct
holding OTLC Common Stock 16,780,384 14 Jun 2023 By Autotelic, Inc.
holding OTLC Common Stock 6,872,529 14 Jun 2023 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

Dr. Trieu purchased 400,000 shares of Oncotelic Therapeutics, Inc. in his individual capacity on June 14, 2023 from the open market at a price of $0.0326.